中国保健营养（中旬刊）
中國保健營養（中旬刊）
중국보건영양（중순간）
China Hwalth Care & nutrition
2012年
z1期
354-355
,共2页
温针灸%非那雄胺%保列治%良性前列腺增生症
溫針灸%非那雄胺%保列治%良性前列腺增生癥
온침구%비나웅알%보렬치%량성전렬선증생증
needle warming moxibustion%proscar%benign prostatic hyperplasia%eld%Drug therapy
目的:观察温针灸联合非那雄胺治疗老年良性前列腺增生症患者的临床疗效.方法:对90例患者随机分成3组:温针灸组(关元穴、三阴交、阴陵泉等)、保列治组(5mg/d)和联合治疗组(温针灸0.2 mg/d,保列治5mg/d),观察周期为3个月.评价三组患者治疗前后国际前列腺症状评分(IPSS)、最大尿流率为(Qmax)、膀胱残余尿量(PRV)和前列腺体积(PV),并用SPSS17.0进行组内和组间比较的统计学处理.结果:与治疗前比较,三组患者经治疗后IPSS评分和RV降低,Qmax升高.此外,保列治组和联合治疗组患者的V均较前降低(P<0.05).分别与温针灸组和保列治组比较,联合治疗组患者经治疗后,IPSS评分、RV和V降低程度,以及Qmax升高程度更为明显(P<0.05).与温针灸组比较,保列治组患者 V 降低程度更为明显(P<0.05).结论:联合应用温针灸和非那雄胺能明显改善老年良性前列腺增生症的临床症状,疗效安全有效,值得临床推广.
目的:觀察溫針灸聯閤非那雄胺治療老年良性前列腺增生癥患者的臨床療效.方法:對90例患者隨機分成3組:溫針灸組(關元穴、三陰交、陰陵泉等)、保列治組(5mg/d)和聯閤治療組(溫針灸0.2 mg/d,保列治5mg/d),觀察週期為3箇月.評價三組患者治療前後國際前列腺癥狀評分(IPSS)、最大尿流率為(Qmax)、膀胱殘餘尿量(PRV)和前列腺體積(PV),併用SPSS17.0進行組內和組間比較的統計學處理.結果:與治療前比較,三組患者經治療後IPSS評分和RV降低,Qmax升高.此外,保列治組和聯閤治療組患者的V均較前降低(P<0.05).分彆與溫針灸組和保列治組比較,聯閤治療組患者經治療後,IPSS評分、RV和V降低程度,以及Qmax升高程度更為明顯(P<0.05).與溫針灸組比較,保列治組患者 V 降低程度更為明顯(P<0.05).結論:聯閤應用溫針灸和非那雄胺能明顯改善老年良性前列腺增生癥的臨床癥狀,療效安全有效,值得臨床推廣.
목적:관찰온침구연합비나웅알치료노년량성전렬선증생증환자적림상료효.방법:대90례환자수궤분성3조:온침구조(관원혈、삼음교、음릉천등)、보렬치조(5mg/d)화연합치료조(온침구0.2 mg/d,보렬치5mg/d),관찰주기위3개월.평개삼조환자치료전후국제전렬선증상평분(IPSS)、최대뇨류솔위(Qmax)、방광잔여뇨량(PRV)화전렬선체적(PV),병용SPSS17.0진행조내화조간비교적통계학처리.결과:여치료전비교,삼조환자경치료후IPSS평분화RV강저,Qmax승고.차외,보렬치조화연합치료조환자적V균교전강저(P<0.05).분별여온침구조화보렬치조비교,연합치료조환자경치료후,IPSS평분、RV화V강저정도,이급Qmax승고정도경위명현(P<0.05).여온침구조비교,보렬치조환자 V 강저정도경위명현(P<0.05).결론:연합응용온침구화비나웅알능명현개선노년량성전렬선증생증적림상증상,료효안전유효,치득림상추엄.
Objective:To observe the clinical safety and efficacy of Needle warming moxibustion and Proscar in the treatment of eld benign prostatic hyperplasia (BPH). Methods:ninety patients with BPH were randomly assigned into 3 groups:needle warming moxibustion group, proscar (5mg/d) group, and Combination therapy (needle warming moxibustion , and proscar 5mg/d) group. After 3 mouths, the international prostate symptom score (IPSS), the maximal urinary flow rate (Qmax), postvoid residual volume (PRV), prostate volume (PV) were analyzed with SPSS 17.0 in the 3 groups. Results:①The diffierences of proscar group and Combination therapy group patients in IPSS, Qmax, PRV and PV before and after the treatment were statistically significant (P<.05), and except for PV, needle warming moxibustion group patients was the same to other groups.②Compare with needle warming moxibustion group and proscar group, the IPSS, Qmax, PRV and PV of the Combination therapy group patients were Significant improvement (P<.05).Conclusion:The therapy of proscar and needle warming moxibustion is obviously effective to improve the clinical symptoms of Patients with BPH, which is safety and effective, and should be clinically popularized.
